Published Clinical Studies

In addition to the published clinical studies listed below, additional peer-reviewed studies on BCL6 are expected to be published in 2019. Please check back as we update these references often.

January 2019
Medical or surgical treatment before embryo transfer improves outcomes in women with abnormal endometrial BCL6 expression.

Creighton E. Likes, Leah J. Cooper, Jessica Efird, David A. Forstein, Paul B. Miller, Ricardo Savaris, Bruce A. Lessey

December, 2017
Endometrial BCL6 testing for the prediction of in vitro fertilization outcomes.

Laura D. Almquist, M.D., Creighton E. Likes, M.D., Benjamin Stone, B.S., Kaitlin R. Brown, B.S., Ricardo Savaris, M.D., Ph.D., David A. Forstein, D.O., Paul B. Miller, M.D., Bruce A. Lessey, M.D., Ph.D.

Gynecol Obstet Invest. 1994;37(3):191-5
Infertility due to diseased pelvic peritoneum: laparoscopic treatment

Manhes H, Shulman A, Haag T, Canis M, Demontmarin JL.

July 28, 2017
KRAS Activation and overexpression of SIRT1/BCL6 Contributes to the Pathogenesis of Endometriosis and Progesterone Resistance.

Jung-Yoon Yoo1,2, Tae Hoon Kim1, Asgerally T. Fazleabas1,3, Wilder A. Palomino4, Soo Hyun Ahn 5, Chandrakant Tayade5, David P. Schammel6, Steven L. Young7, Jae-Wook Jeong1,3 & Bruce A. Lessey8.

Fertil Steril. 2011 Mar 1;95(3):1113-4. doi: 10.1016/j.fertnstert.2010.12.017
Increased diagnostic accuracy of laparoscopy in endometriosis using indigo carmine: a new technique.

Rauh-Hain JA, Laufer MR.

Fertil Steril. 2011 Sep;96(3):e145; author reply e146. doi: 10.1016/j.fertnstert.2011.06.02
Does complete laparoscopic excision of endometriosis in teenagers really occur?

Laufer MR, Missmer SA.

Reprod Sci. 2016 Sep;23(9):1234-41
Endometrial BCL6 Overexpression in Eutopic endometrium of women with endometriosis.

Evans-Hoeker E, Lessey BA, Jeong JW, Savaris RF, Palomino WA, Yuan L, Schammel DP, Young SL.

Semin Reprod Med. 2010 Jan;28(1):5-16. doi: 10.1055/s-0029-1242988
Progesterone function in human endometrium: clinical perspectives.

Young SL, Lessey BA.

The ReceptivaDxTM Test was developed by CiceroDx in conjunction with Pathology Consultants, Inc. of Greenville, SC. Pathology Consultants, Inc. is a laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA). As with other laboratory-developed tests, this testing service has not been cleared or approved by the US FDA or any other federal regulatory agencies. Data have not been submitted to or evaluated by Federal regulatory agencies and the test is not for sale as an In Vitro Diagnostic (IVD) in the US or the EU.


Copyright © 2019 ReceptivaDx™ | All Rights Reserved